Actively Recruiting
Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations
Led by Universitat Autonoma de Barcelona · Updated on 2026-03-27
55
Participants Needed
2
Research Sites
6 weeks
Total Duration
On this page
Sponsors
U
Universitat Autonoma de Barcelona
Lead Sponsor
G
Grup ATRA
Collaborating Sponsor
AI-Summary
What this Trial Is About
Aurora is an interdisciplinary project evaluating a chatbot-mediated supportive care intervention designed to promote emotional expression, autobiographical meaning-making, identity processes, and emotional well-being through guided narrative reconstruction. The Aurora system provides a structured, person-centered storytelling process supported by generative AI and human facilitation. Under the supervision of a trained facilitator (licensed mental health professional), participants engage in guided reminiscence and storytelling sessions to co-create a personalized "life book." The chatbot is not a diagnostic or treatment tool; rather, it is intended to support emotional expression, narrative reconstruction, and recovery-oriented processes. The study includes three non-randomized arms implemented sequentially: (1) a single-session arm of healthy adults focused on acceptability, usability, and emotional safety; (2) a four-hour intervention arm of adults with DSM-5 diagnosed mental disorders in residential care; and (3) a four-hour intervention arm of healthy older adults aged 65 years and older. Quantitative outcomes assess affect, mental well-being, and recovery-related constructs. Additional measures include usability, satisfaction, and qualitative feedback. Ecological momentary assessment (EMA) is conducted in Arms 2 and 3.
CONDITIONS
Official Title
Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- For Arm 1 (Healthy Adults): Age 18 years or older at screening.
- Able to read and understand Spanish to follow study instructions and complete questionnaires.
- Able to engage in a brief guided interaction and complete self-report measures.
- Willing and able to provide written informed consent.
- For Arm 2 (Adults with DSM-5 Mental Disorder in Residential Care): Age 18 years or older at screening.
- Currently living in a participating long-term mental health residential care facility with expected stay through intervention and post-assessment.
- Documented DSM-5 diagnosis confirmed by treating clinician.
- Clinically stable with no acute psychiatric hospitalization or crisis intervention in prior 4 weeks.
- Clinical Global Impression-Improvement score between 3 and 5 in prior 4 weeks.
- Able to understand spoken and written Spanish.
- Able to engage in guided interaction and provide feedback.
- Willing and able to provide informed consent; legal guardian consent and participant assent if applicable.
- Willing to participate in all study procedures.
- For Arm 3 (Healthy Older Adults): Age 65 years or older at screening.
- No self-reported serious mental disorder (e.g., psychotic disorder or bipolar disorder).
- Able to read and understand Spanish.
- Adequate cognitive and communication abilities to engage and complete questionnaires.
- Willing and able to provide written informed consent.
You will not qualify if you...
- For Arm 1 (Healthy Adults): Current acute medical or psychiatric condition that risks safe participation or data validity.
- Moderate or high suicide or self-harm risk at screening.
- Significant cognitive, communication, or comprehension impairments.
- Explicit refusal to participate.
- For Arm 2 (Adults with DSM-5 Mental Disorder in Residential Care): Current acute psychiatric decompensation requiring crisis care.
- Moderate or high suicide or self-harm risk at screening or baseline.
- High risk of emotional harm from life review as judged by clinician due to recent clinical destabilization, trauma symptoms, or dissociation.
- Inability to provide informed consent without legal representative or participant assent.
- Significant cognitive, communication, or comprehension impairments without support.
- Explicit refusal to participate.
- Imminent discharge or transfer preventing intervention or follow-up completion.
- For Arm 3 (Healthy Older Adults): Self-reported serious mental disorder (e.g., psychotic or bipolar disorder).
- Moderate or high suicide or self-harm risk at screening.
- Current acute medical or psychiatric condition risking safe participation.
- Significant cognitive, communication, or comprehension impairments.
- Explicit refusal to participate.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Llar Residència Gràcia(Grup ATRA)
Barcelona, Barcelona, Spain, 08012
Not Yet Recruiting
2
Department of Clinical and Health Psychology; Universitat Autònoma de Barcelona
Cerdanyola del Vallès, Barcelona, Spain, 08193
Actively Recruiting
Research Team
A
Albert Feliu-Soler Associate Professor Serra Húnter Fellow, PhD
CONTACT
J
Jaime Navarrete Postdoctoral Researcher, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here